| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10902487 | Cancer Letters | 2005 | 7 Pages |
Abstract
In conclusion, the p53 status cannot predict paclitaxel/Taxol® sensitivity in RCC cell lines of the clear cell type.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Petra Reinecke, Thomas Kalinski, Csaba Mahotka, Michael Schmitz, Marion Déjosez, Helmut Erich Gabbert, Claus Dieter Gerharz,